Overview
Clinical phenotype terms— hover any for plain English:
FDA & Trial Timeline
3 eventsKaken Pharmaceutical — PHASE3
University Hospital, Grenoble — NA
Hospital Italiano de Buenos Aires
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Capillary-lymphatic-venous malformation with segmental distribution.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Capillary-lymphatic-venous malformation with segmental distribution.
Community
No community posts yet. Be the first to share your experience with Capillary-lymphatic-venous malformation with segmental distribution.
Start the conversation →Latest news about Capillary-lymphatic-venous malformation with segmental distribution
Disease timeline:
New recruiting trial: A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
A new clinical trial is recruiting patients for Capillary-lymphatic-venous malformation with segmental distribution
New recruiting trial: Longitudinal Neuroimaging in Sturge-Weber Syndrome
A new clinical trial is recruiting patients for Capillary-lymphatic-venous malformation with segmental distribution
New recruiting trial: Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome
A new clinical trial is recruiting patients for Capillary-lymphatic-venous malformation with segmental distribution
New recruiting trial: Institutional Registry of Haemorrhagic Hereditary Telangiectasia
A new clinical trial is recruiting patients for Capillary-lymphatic-venous malformation with segmental distribution
New recruiting trial: Identification of Biomarkers for Patients with Vascular Anomalies
A new clinical trial is recruiting patients for Capillary-lymphatic-venous malformation with segmental distribution
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Capillary-lymphatic-venous malformation with segmental distribution
Are there clinical trials for Capillary-lymphatic-venous malformation with segmental distribution?
Yes — 1 recruiting clinical trial is currently listed for Capillary-lymphatic-venous malformation with segmental distribution on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Capillary-lymphatic-venous malformation with segmental distribution?
1 specialists and care centers treating Capillary-lymphatic-venous malformation with segmental distribution are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.